Jun 28, 2024, 13:32
Updated results from the TRANSMET trial at ESMOGI24
ESMO shared on X:
“ESMOGI24: Updated results from the TRANSMET trial showed that chemotherapy combined with liver transplantation in highly selected patients with CRC quadrupled the 5-year OS rate VS chemotherapy alone.
Link to ESMO Daily Reporter.”
Source: ESMO/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 23, 2024, 16:25
Oct 23, 2024, 16:03
Oct 23, 2024, 15:44
Oct 23, 2024, 15:44
Oct 23, 2024, 15:42
Oct 23, 2024, 15:15